├── saRNA_vaccine_DS_production_modelling.spf
├── saRNA_vaccine_DS_production_TEA_modelling_assumption&results.xlsx
└── README.md


/saRNA_vaccine_DS_production_modelling.spf:
--------------------------------------------------------------------------------
https://raw.githubusercontent.com/ZKis-ZK/RNA-vaccine-drug-substance-production-techno-economic-modelling/HEAD/saRNA_vaccine_DS_production_modelling.spf


--------------------------------------------------------------------------------
/saRNA_vaccine_DS_production_TEA_modelling_assumption&results.xlsx:
--------------------------------------------------------------------------------
https://raw.githubusercontent.com/ZKis-ZK/RNA-vaccine-drug-substance-production-techno-economic-modelling/HEAD/saRNA_vaccine_DS_production_TEA_modelling_assumption&results.xlsx


--------------------------------------------------------------------------------
/README.md:
--------------------------------------------------------------------------------
 1 | # RNA vaccine drug substance production techno-economic modelling
 2 | 
 3 | Modelling files related to the journal article titled "Rapid development and deployment of high-volume vaccines for pandemic response" submitted for publication to the Journal of Advanced Manufacturing and Processing (JAMP). Year: 2020. Article Authors: Zoltán Kis, Cleo Kontoravdi, Antu K. Dey, Robin Shattock, Nilay Shah
 4 | 
 5 | 
 6 | This repository contains the following files:
 7 | - the SuperPro Designer Version 11, Build 2 (Intelligen, Inc.) model of RNA vaccine drug substance production process ("saRNA_vaccine_DS_production_modelling.spf");
 8 | - the economic evaluation report generated by SuperPro Designer ("saRNA_vaccine_DS_production_modelling_EER.rtf");
 9 | - the Excel file were the assumptions, techno-economic calculations and results are shown ("saRNA_vaccine_DS_production_TEA_modelling_assumption&results.xlsx").
10 | 
11 | 
12 | Acknowledgements:
13 | This research is funded by the Department of Health and Social Care using UK Aid funding and is managed by the Engineering and Physical Sciences Research Council (EPSRC, grant number: EP/R013764/1). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health and Social Care.
14 | 


--------------------------------------------------------------------------------